This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nantbio, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Charles Vaske: Innovator in Neoepitope Payload Toxicity
Introduction
Charles Vaske is a notable inventor based in Culver City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of neoepitope payload toxicity. His work is essential for advancing therapeutic methods and improving patient outcomes.
Latest Patents
Charles Vaske holds a patent titled "Machine Methods To Determine Neoepitope Payload Toxicity." This patent represents his innovative approach to assessing the safety and efficacy of therapeutic payloads, which is crucial in the development of targeted therapies.
Career Highlights
Currently, Charles Vaske is employed at Nantbio, Inc., where he continues to push the boundaries of biotechnological research. His expertise and dedication to innovation have positioned him as a valuable asset in his field.
Collaborations
Charles has collaborated with talented individuals such as Lise Geissert and Christopher W. Szeto. These partnerships enhance the research environment and foster the development of groundbreaking solutions in biotechnology.
Conclusion
Charles Vaske's contributions to the field of neoepitope payload toxicity exemplify the impact of innovative thinking in biotechnology. His work at Nantbio, Inc. and his collaborations with esteemed colleagues highlight his commitment to advancing medical science.